ALK and non-small cell lung carcinoma: The most widely recognised genomic alterations in NSCLC include epidermal growth factor receptor (EGFR) mutations and echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase (EML-ALK) fusion gene mutations.